Innovation1 Biotech Inc.
IVBT
$0.0002
-$0.0006-75.00%
OTC PK
| 11/30/2023 | 08/31/2023 | 05/31/2023 | 02/28/2023 | 11/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -255.20K | -4.45M | -298.90K | -603.40K | -631.70K |
| Total Depreciation and Amortization | 300.00 | 300.00 | 300.00 | 300.00 | 51.90K |
| Total Amortization of Deferred Charges | 94.30K | -- | -- | -2.70K | 2.70K |
| Total Other Non-Cash Items | -- | 3.59M | 149.70K | 304.40K | 0.00 |
| Change in Net Operating Assets | 9.80K | 839.00K | -40.40K | 92.60K | 381.80K |
| Cash from Operations | -150.90K | -26.90K | -189.30K | -208.80K | -195.20K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 106.90K | 0.00 | 213.60K | 250.00K | 50.00K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 106.90K | 0.00 | 213.60K | 250.00K | 50.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | 0.00 | 0.00 | -- | -- |
| Net Change in Cash | -44.00K | -26.90K | 24.20K | 41.20K | -145.20K |